Calliditas Therapeutics AB (CALT)
19.00
-0.94
(-4.70%)
USD |
NASDAQ |
May 02, 16:00
19.57
+0.57
(+2.99%)
After-Hours: 20:00
Calliditas Therapeutics Shareholders Equity (Quarterly): 33.26M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.26M |
| September 30, 2023 | 32.29M |
| June 30, 2023 | 46.45M |
| December 31, 2022 | 73.52M |
| September 30, 2022 | 65.18M |
| June 30, 2022 | 70.57M |
| March 31, 2022 | 94.32M |
| December 31, 2021 | 111.45M |
| September 30, 2021 | 143.50M |
| June 30, 2021 | 110.10M |
| March 31, 2021 | 125.64M |
| December 31, 2020 | 147.82M |
| Date | Value |
|---|---|
| September 30, 2020 | 153.56M |
| June 30, 2020 | 152.86M |
| March 31, 2020 | 72.26M |
| December 31, 2019 | 84.33M |
| September 30, 2019 | 82.80M |
| June 30, 2019 | 71.11M |
| March 31, 2019 | 61.93M |
| December 31, 2018 | 68.84M |
| September 30, 2018 | 74.23M |
| June 30, 2018 | 0.8118M |
| March 31, 2018 | 2.991M |
| December 31, 2017 | 4.057M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
32.29M
Minimum
Sep 2023
153.56M
Maximum
Sep 2020
92.83M
Average
83.57M
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 140.19M |
| Cellectis SA | 84.70M |
| Adaptimmune Therapeutics PLC | 39.51M |
| Akari Therapeutics PLC | -0.229M |
| Biodexa Pharmaceuticals Plc | 5.959M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 184.69M |
| Total Liabilities (Quarterly) | 151.43M |
| Debt to Equity Ratio | 2.806 |
| Current Ratio | 3.132 |
| Net Debt Paydown Yield | -1.46% |